News & Insights

SolentimNews & Insights
Insights matthews

Postcard from BPI Europe in Vienna – Highlights of the Cell Line Development Stream

This annual meeting in early Spring is always a good forum for major new product and technology announcements. In previous years, discussions often mainly centred around assurance of clonality and the requirements of the FDA – still a key consideration for cell line development. Recently, however, the market has expanded from a focus on monoclonal …

Read more Postcard from BPI Europe in Vienna – Highlights of the Cell Line Development Stream

Conferences sciadseo

Conference News Item: Solentim presenting two posters at ESACT 2019

Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be attending the 26th ESACT Meeting, 5th – 8th May 2019 in Copenhagen, Denmark. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth to discuss our latest products and collaborations. The theme of …

Read more Conference News Item: Solentim presenting two posters at ESACT 2019

Corporate sciadseo

Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies

A consortium, consisting of Valitacell, Solentim and Microcoat, has been awarded €2.5million under the highly competitive H2020 Fast Track to Innovation (FTI) initiative, and a further €1million from other sources Solentim and Valitacell announce a total of €3.5m funding to produce an integrated platform to deposit, culture, profile and select optimal cells for the manufacture of life-saving …

Read more Valitacell and Solentim secure €3.5m funding to optimise the development of new biologics and cell therapies

Conferences sciadseo

Solentim, along with collaborator Janssen, and partners ATUM and Valitacell, will be making a splash at BPI Europe

Solentim, a global leader in cell line development instrumentation, will be attending and exhibiting at BPI Europe, 2-5 April, in Vienna, Austria. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth (#83) to discuss our latest innovations and to answer any questions. Also speaking at the event will …

Read more Solentim, along with collaborator Janssen, and partners ATUM and Valitacell, will be making a splash at BPI Europe

Insights matthews

Important considerations for optimising outgrowth from single cells in cloning plates during cell line development

When developing biotherapeutics there are many parts of the process that require optimisation. Cell line development is a key part of this process and there are many aspects where changes can have a dramatic effect on timelines and outcomes. One key area which is challenging to many of our customers is outgrowth of clones in …

Read more Important considerations for optimising outgrowth from single cells in cloning plates during cell line development

Conferences sciadseo

Connect with Solentim at IMAPAC: Biologics World Nordic 2019

Solentim, a global leader in cell line development instrumentation, will be attending IMAPAC’s Biologics World Nordic event, 5-7 March in Stockholm. Experts from the Company will be on hand throughout the event at the Solentim exhibition booth (number 2) to discuss our latest innovations and to answer any questions. The global biologic medicines market is …

Read more Connect with Solentim at IMAPAC: Biologics World Nordic 2019